(Received for publication, November 22, 1996, and in revised form, January 16, 1997)
From the International Research Laboratories, Ciba-Geigy Japan
Ltd., 10-66 Miyuki-cho, Takarazuka 665, Japan and the
Department of Oral Anatomy, Meikai University School of
Dentistry, Sakado 350-02, Japan
Cathepsin K is a recently identified cysteine protease which is abundantly and selectively expressed in osteoclasts. To evaluate the contribution of cathepsin K to bone resorption processes, we investigated the effect of cathepsin K antisense phosphothiorate oligodeoxynucleotide (S-ODN) on the bone-resorbing activity of osteoclasts. Rabbit osteoclasts were cultured on dentine slices for 24 h in the presence or absence of antisense S-ODN in a medium containing 100 nM TfxTM-50, polycationic liposome, as a carrier of the S-ODN. Uptake of the S-ODN by osteoclasts was confirmed microscopically using fluorescein-labeled S-ODN. The treatment with antisense significantly decreased the amount of cathepsin K protein in osteoclasts. The antisense inhibited the osteoclastic pit formation in a concentration-dependent fashion. At 10 µM the antisense reduced the total pit number and area and average pit depth by 46, 52, and 30%, respectively. The sense and mismatch S-ODNs, which were used as negative controls, had no effect on either the cathepsin K protein level or the pit formation. A nonspecific cysteine protease inhibitor, E-64, also reduced pit formation in a concentration-dependent manner with maximum reductions at 1 µM of 46, 48, and 35% in the above pit parameters. The inhibitory effect of the antisense almost equal to that of E-64 demonstrates that cathepsin K is a cysteine protease playing a crucial role in osteoclastic bone resorption.
Bone tissue is a composite matrix comprising of hydroxyapatite and fibrous proteins (mainly Type I collagen) and is constantly subjected to a cycle of bone resorption and bone formation (1). Bone resorption is mainly carried out by osteoclasts which are multinucleate giant cells. In osteoclastic bone resorption, demineralization, in which osteoclasts release protons to solubilize the inorganic salt (2), is followed by the degradation of the protein fibers with cysteine proteases (1, 3). The involvement of the cysteine proteases has been verified in both in vitro and in vivo studies showing that various types of cysteine protease inhibitors reduce bone resorption (1, 3-10). From studies based on substrate preference, inhibitor preference, and immunoreactivity, the cathepsins L and B were suggested to be responsible for osteoclastic bone resorption processes (8-14).
Recently, several research laboratories (including our own) have successfully cloned cDNAs for a novel cysteine protease, namely cathepsin K, from rabbit and human cDNA libraries (15-19), and its role in bone resorption has been the focus of recent attention. Human cathepsin K is highly and selectively expressed in osteoclasts (16-21); in fact its expression level is much greater than those of cathepsins B, L, and S (20, 21). Brömme et al. (22) and Bossard et al. (23) showed that cathepsin K expresses a potent proteolytic activity against Type I collagen. Saneshige et al. (24) demonstrated that retinoic acid, a vitamin A metabolite, both up-regulates the gene expression of cathepsin K in osteoclasts and increases osteoclastic bone resorption. Moreover, Gelb et al. (25) reported that a deficiency of cathepsin K causes pyknodysostosis, which is an inherited sclerosing skeletal dysplasia. These findings strongly suggest that cathepsin K is critically involved in bone resorption, but the direct evidence to prove the role of cathepsin K in bone resorption is not provided.
For the first time, based on the investigation of the inhibitory effect of cathepsin K antisense S-ODN1 on osteoclast-mediated pit formation, we herein describe the significant role of cathepsin K in osteoclastic bone resorption.
Acid hematoxylin and E-64
(trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane)
were purchased from Sigma. -Minimum essential medium (
-MEM) was obtained from Flow Laboratories (McLean, VA), and
fetal bovine serum (FBS) was purchased from Life Technologies, Inc.
TfxTM-50, a mixture of cationic lipid
(N,N,N
,N
-tetramethyl-N,N
-bis(2-hydroxyethyl)-2,3-dioleoyloxy-1,4-butanediammonium iodide) and L-dioleoylphosphatidylethanolamine was
purchased from Promega.
The cathepsin K antisense
S-ODN was designed to be composed of 20 bases and targeted to the
region that spans the translation start codon of the rabbit cathepsin K
mRNA (Table I). The sense and three 4-base
mismatches (MS1, MS2, and MS3) to the antisense S-ODN were also
designed as negative controls (Table I). All these S-ODNs were
synthesized (Sawaday, Inc., Tokyo, Japan) on an automated solid-phase
nucleotide synthesizer and subsequently filter-sterilized. The GC
content was the same among these S-ODNs. A fraction of the synthesized
S-ODNs were labeled with fluorescein at the 5 ends.
|
Long bones were
taken from 10-day-old rabbits. After careful removal of the adhered
soft tissue, the bones were minced with scissors for 10 min in -MEM
containing 5% FBS. Cells were dissociated from the bone fragments by
sedimentation under normal gravity for 3 min after mild stirring for
30 s. The supernatant was used as unfractionated bone cells. The
cells were incubated on dentine slices (150 µm thick and 6 mm in
diameter) at a concentration of 4 × 105 cells/slice
in 96-well tissue culture plates in the presence or absence of the
antisense or control S-ODNs in
-MEM containing 5% FBS and 100 nM TfxTM-50 as the S-ODN carrier. Then they
were cultured for 8 h in an incubator with 10% CO2 at
37 °C. After an 8-h incubation, the medium was exchanged for fresh
medium containing S-ODNs, and the incubation continued for an
additional 16 h.
For the experiments examining the effect of E-64, the cells were
incubated on dentine slices in -MEM containing 5% FBS and various
concentrations of E-64 with 10% CO2 at 37 °C for
24 h.
After the 24-h cultivation period, the cells were brushed off the dentine slices with a rubber policeman, and the slices were washed in distilled water and stained with acid hematoxylin for 2 min. Total number and area of pits on each dentine slice were counted manually under a light microscope (Nikon, Tokyo, Japan) equipped with a micrometer (giving 625 µm2 for each square) on the eyepiece (objective lens, ×20). For depth measurement, we selected 10 pits/slice having approximately the same area of 1000-1500 µm2. A scanning surface profiler (TENCOR Instruments) was used to determine the deepest point of each pit. In this study, the pits that were produced by osteoclasts on dentine slices in the absence of S-ODNs or E-64 had an average area of 1460 ± 200 µm2 (total pit area/pit number, n = 7) and average depth of 5.95 ± 0.16 µm (n = 70).
Fluorescence MicroscopyFluorescence microscopy was used to
detect the uptake of fluorescein-labeled cathepsin K antisense S-ODN by
osteoclasts. Rabbit osteoclasts isolated according to the method of
Tezuka et al. (26) were cultured in -MEM containing 5%
FBS, 100 nM TfxTM-50, and fluorescein-labeled
cathepsin K antisense S-ODN for 24 h. After removing the
incubation media from the culture plates at the end of cultivation
period, the cells were washed three times with phosphate-buffered
saline (PBS) and fixed with 4% formaldehyde in PBS for 10 min at room
temperature. The cells were dehydrated in ethanol (40, 70, and then
100%) for 10 min on ice, rinsed in PBS, and photographed with a camera
fitted to a X2F-EFD2 fluorescence microscope (Nikon, Japan).
The osteoclasts were cultured for
8 h in -MEM containing 5% FBS and 100 nM
TfxTM-50 in the presence or absence of 10 µM
S-ODNs. After a medium change, to a fresh one containing the same
constituents, the cells were cultured for an additional 16 h. The
osteoclasts on the dishes were scraped off in PBS with a rubber
policeman. After complete disruption of the cells by sonication,
lysates were subjected to centrifugation at 10,000 × g
for 10 min. The membrane fraction was then subjected to SDS-PAGE (14%
gel), followed by electroblotting to a polyvinylidene difluoride (PVDF)
membrane (Bio-Rad). The membrane was treated with the chick antibody
(IgY) against rabbit cathepsin K (27), followed by the anti-IgY
antibody conjugated with horseradish peroxidase (Promega).
Immunoreactive bands were visualized using a Konica immunostain kit
(Konica, Tokyo, Japan).
Data are expressed as mean ± S.E. The statistical significance between the control and the experimental groups was assessed by a Student's t test. p < 0.05 was considered to be significant.
The effect of the polycationic liposome TfxTM-50 on pit formation was investigated to determine the optimal transfection conditions for osteoclasts. Results show that TfxTM-50 of 100 nM to 300 nM had a negligible effect on osteoclastic pit formation (pit number, area, and depth). However, at higher concentrations of 1-10 µM, TfxTM-50 reduced pit formation in a concentration-dependent manner, in particular a concentration of 10 µM produced large reductions (data not shown). Hence, treatment with high concentrations of TfxTM-50 probably induces a cytotoxic effect on osteoclasts. We therefore used TfxTM-50 at a concentration of 100 nM as a carrier to introduce the S-ODNs into osteoclasts in further experiments.
Uptake of S-ODNs and ViabilityThe uptake of the cathepsin K
antisense S-ODN by osteoclasts was confirmed by fluorescence
microscopy. Fig. 1A shows a phase contrast
photograph of osteoclasts loaded with fluorescein-labeled antisense
S-ODN (10 µM). The intense fluorescence in both the cytoplasm and nuclei, as shown in Fig. 1B, indicates that
the antisense S-ODN entered the osteoclasts and reached the inside of
the nuclei by liposome-mediated transfection. The sense S-ODN and the
three 4-base mismatches to the antisense S-ODN (MS1 S-ODN to MS3 S-ODN)
were also introduced in a similar fashion (data not shown). At
concentrations of S-ODNs up to 10 µM there were no
cytotoxic effects on osteoclasts as determined by trypan blue staining
(data not shown).
Western Blot Analysis of Cathepsin K
The antisense
S-ODN-treated osteoclasts showed a marked decrease in the protein level
of both the pro form (38 kDa) and the mature form (27 kDa)
of cathepsin K, compared with untreated osteoclasts (Fig.
2A). On the other hand, the MS1 S-ODN
treatment did not alter the protein levels of cathepsin K (Fig.
2B). No change of the protein levels of cathepsin K was
observed with sense S-ODN, MS2 S-ODN, and MS3 S-ODN treatment (data not
shown). These results clearly indicate that the antisense S-ODN was
targeted to cathepsin K mRNA and inhibited the synthesis of
cathepsin K protein.
Pit Formation Assay
The effect of the cathepsin K antisense
S-ODN on osteoclastic bone resorption was investigated by the pit
formation assay. By detailed examination of the pit number, area, and
depth, the antisense S-ODN was found to decrease osteoclastic pit
formation in a concentration-dependent manner (Fig.
3A). In a comparison with control values, the
antisense S-ODN (10 µM) caused a maximum reduction of
46% (p < 0.05), 52% (p < 0.01), and
30% (p < 0.01) in total pit number and area and
average depth, respectively. The effect of E-64, a potent and
non-selective cysteine protease inhibitor, was also investigated by the
pit formation assay. As shown in Fig. 3B, E-64 caused a
concentration-dependent inhibition of the pit formation in
the range of 10 nM to 1 µM. At 1 µM E-64 reduced the pit number, area, and depth by 46%
(p < 0.05), 48% (p < 0.05), and 35%
(p < 0.01), respectively. A higher concentration of
E-64, 10 µM, did not show further inhibition in these pit
parameters. Consequently, these results indicate that the inhibitory
effect of the cathepsin K antisense S-ODN on osteoclastic bone
resorption is almost equal to that of E-64.
The reductions of the total pit area by the antisense and E-64 were greatly attributed to the decrease in pit number, as the average area of each pit for the treatment with the antisense (1150 ± 70 µm2) or E-64 (1300 ± 170 µm2) was not significantly different from that in the control cultures (1460 ± 200 µm2). This result showed that the cathepsin K antisense and E-64 reduced the resorbed pit number and depth, but did not intrinsically affect the surface area of individual pits.
As a series of control experiments, we investigated the effects of the sense and mismatch (MS1, MS2, MS3) S-ODNs on the pit formation. All these S-ODNs did not show any inhibitory effects on pit formation at concentrations up to 10 µM (see Fig. 3C for a representative example). These results confirm the specificity of the cathepsin K antisense to the inhibition of pit formation.
Cathepsin K is a cysteine protease expressed abundantly and selectively in osteoclasts (15-21). Despite data detailing the potent proteolytic activity of cathepsin K for Type I collagen (22, 23), there has been no direct evidence to prove the function of cathepsin K in the osteoclastic bone resorption process. We have utilized antisense S-ODN to cathepsin K mRNA to demonstrate that cathepsin K plays a critical role in bone resorption.
The present study employed S-ODNs, which are more resistant to nucleases as compared with phosphodiesters (28), and the polycationic liposome, TfxTM-50, as a carrier. Employing 100 nM TfxTM-50, a concentration which did not manifest cytotoxicity, the uptake of S-ODNs by osteoclasts was microscopically confirmed using fluorescein-labeled S-ODNs (Fig. 1). In the absence of TfxTM-50, the cathepsin K antisense S-ODN did not significantly inhibit osteoclastic bone resorption (data not shown). Therefore, the liposomal carrier system, employing TfxTM-50, functions effectively to introduce S-ODNs into the osteoclasts.
The cathepsin K antisense S-ODN caused a reduction in the cathepsin K protein levels in osteoclasts, which was correlated with a reduction in the pit formation, reaching a maximum inhibition of total pit number and area of approximately 50% and average pit depth of 30%. These effects were not observed for the sense S-ODN or the S-ODNs having 20% mismatch sequences. The cDNA sequences between rabbit cathepsin K and rabbit cathepsins L, B, and S share only 56, 51, and 56% homology, respectively, and the cathepsin K antisense used for the present study was found to be less than 70% homologous to any region on the antisense strands of the cDNAs for rabbit cathepsins L, B, and S.2 These results suggest that the antisense suppressed osteoclastic bone resorption by specifically blocking the expression of cathepsin K, while having no influence on the expression of cathepsins L, B, or S in osteoclasts. The nonspecific and potent inhibitor of cysteine proteases E-64 similarly reduced the osteoclastic pit formation by a maximum of approximately 50% in total pit number and area and of 35% in average pit depth. The present results are in good agreement with the previous reports of Delaissé et al. (6) and Kakegawa et al. (8) examining the effect of E-64 on pit formation (approximately 50% reduction in total pit number (6) and area (8)).
These results suggest that cysteine protease inhibitors or the reduction of cathepsin K cannot completely inhibit pit formation. Since initial pit formation is thought to be mediated by the demineralization of bone by acidification, cysteine protease most likely contributes to later stages of resorption. Indeed, Sundquist et al. (29) and Ohba et al. (30) observed that optimum concentrations of bafilomycin A1, a specific vacuolar H+-ATPase inhibitor, almost completely inhibited bone resorption by blocking osteoclast proton transport. In this study, by the treatment with cathepsin K antisense or E-64, the surface area of bone resorbed was not intrinsically affected, while the pit depth was significantly reduced. This suggests that the inhibition of cysteine protease impairs continuation of the process of cavitation, without significantly affecting the initial pit formation. This suggestion is supported by the fact previously reported by Delaissé et al. (3, 4) that E-64 or another cysteine protease inhibitor, leupeptin, showed more inhibition of collagen degradation than calcium loss in resorbing mouse calvaria. However, both cathepsin K antisense and E-64 also reduced the pit number. It was confirmed that the present experimental conditions did not affect the viability of osteoclasts. One possible explanation for the reduction of the pit number is that there might be a relative increase in the number of undetectable indentations, where the initial process of demineralization has occurred, but true cavity formation has been constrained. Alternatively, a subpopulation of osteoclasts might enter a resting state by the interference of the collagen degradation.
In conclusion, cathepsin K antisense effectively inhibited the osteoclast-mediated pit formation by the selective suppression of the protein synthesis of cathepsin K. Although cathepsins L and B have been proposed to be important in osteoclastic bone resorption, it has recently been demonstrated that they are expressed at much lower levels in osteoclasts than cathepsin K (20, 21). In the present study, the inhibitory effectiveness of the cathepsin K antisense on the pit formation was found to be almost equal to that of E-64. This clearly suggests that degradation of the protein component in bone matrix is mediated primarily by the action of cathepsin K. This is the first evidence that cathepsin K is directly involved in osteoclastic bone resorption. Specific inhibitors of cathepsin K could be therapeutically expected to counteract pathological states such as osteoporosis.
We thank Dr. B. Goldsmith for discussions and critical reading of the manuscript and M. Tanaka for excellent technical assistance with the pit formation assay.